Retatrutide vs Tirzepatide vs Semaglutide
A side-by-side look at three incretin-class research peptides from Honest Science, a Canadian supplier: Retatrutide, Tirzepatide and Semaglutide, all listed in the Metabolic Activation category. All three are sold for laboratory research only.
Vial sizes, prices and batch purity
| Compound | Vial size | Price (CAD) | Latest batch purity | Availability |
|---|---|---|---|---|
| Retatrutide | 15mg30mg | $179.99 CAD (15mg)$299.00 CAD (30mg) | 99.763% (30mg vial) Batch 2026/4, tested April 24, 2026 | In stock — view product |
| Tirzepatide | 10mg | $139.99 CAD | 99.906% Batch 2026/4, tested April 24, 2026 | In stock — view product |
| Semaglutide | 5mg | $114.99 CAD | No certificate published yet | In stock — view product |
Prices are in Canadian dollars. Batch purity is the figure printed on the latest published certificate of analysis.
Side-by-side specifications
| Property | Retatrutide | Tirzepatide | Semaglutide |
|---|---|---|---|
| Receptor class | Triple agonist: GIP, GLP-1 and glucagon receptors | Dual agonist: GIP and GLP-1 receptors | Single agonist: GLP-1 receptor |
| Category | Metabolic Activation | Metabolic Activation | Metabolic Activation |
| Vial size | 15mg and 30mg | 10mg | 5mg |
| Price | from $179.99 CAD | $139.99 CAD | $114.99 CAD |
| Purity | ≥99% | ≥99% | ≥99% |
| Peptide length | 39 amino acids | 39 amino acids | 31 amino acids |
| Fatty-acid side chain | C20 diacid | C20 diacid | C18 diacid |
| CAS number | 2381089-83-2 | 2023788-19-2 | 910463-68-2 |
| Formula | C221H342N46O68 | C225H348N48O68 | C187H291N45O59 |
| Molecular weight | 4731.33 g/mol | 4813.45 g/mol | 4113.58 g/mol |
| Sequence | Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-(α-Me-Leu)-Leu-Asp-Lys(γGlu-(AEEA)-C20 diacid)-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Pro-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | Tyr-Aib-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(γGlu-(AEEA)2-C20 diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γGlu-(AEEA)2-C18 diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
| Form | Lyophilized powder | Lyophilized powder | Lyophilized powder |
How they differ as research materials
The main difference is how many receptors each peptide targets. Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual agonist of the GIP and GLP-1 receptors. Retatrutide is a triple agonist that adds the glucagon receptor.
All three are modified peptides carrying a fatty diacid side chain, visible in the published sequences: C18 for Semaglutide and C20 for Tirzepatide and Retatrutide.
Tirzepatide and Semaglutide are each offered in one vial size. Retatrutide is offered in two, so its price in the specifications table is the starting price.
Frequently asked questions
How do Retatrutide, Tirzepatide and Semaglutide differ in structure?
All three are synthetic peptides modified with a fatty diacid side chain. Retatrutide and Tirzepatide are 39-amino-acid peptides carrying a C20 diacid; Semaglutide is a 31-amino-acid peptide carrying a C18 diacid. Each has its own sequence, molecular formula and molecular weight, listed in the specifications table above.
Which receptors does each compound target?
Retatrutide is a triple agonist of the GIP, GLP-1 and glucagon receptors. Tirzepatide is a dual agonist of the GIP and GLP-1 receptors. Semaglutide is an agonist of the GLP-1 receptor.
What vial sizes are available?
Honest Science supplies Retatrutide in 15mg and 30mg vials, Tirzepatide in a 10mg vial and Semaglutide in a 5mg vial, each as lyophilized powder.
How is each batch tested?
Every batch is independently third-party tested for identity and purity, and certificates of analysis are published on the product pages and on the certificates page. The latest published results are Retatrutide 30mg batch 2026/4 at 99.763% purity (tested April 24, 2026) and Tirzepatide batch 2026/4 at 99.906% purity (tested April 24, 2026). No certificate is currently published for Semaglutide.
How are the vials supplied and stored?
All three are supplied as lyophilized (freeze-dried) powder. Keep each vial cold, sealed, dry and protected from light, and follow the storage guidance on the batch documentation.
More in the storage and handling guide.
Batch documentation
Every batch of each compound is independently third-party tested for identity and purity. Certificates of analysis are published in one place.
Also see: BPC-157 vs TB-500 vs the blend.
For research use only. Not for human consumption.